Next Step in Gene Delivery: Modern Approaches and Further Perspectives of AAV Tropism Modification
Today, adeno-associated virus (AAV) is an extremely popular choice for gene therapy delivery. The safety profile and simplicity of the genome organization are the decisive advantages which allow us to claim that AAV is currently among the most promising vectors. Several drugs based on AAV have been...
Main Authors: | Maxim A. Korneyenkov, Andrey A. Zamyatnin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/750 |
Similar Items
-
Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
by: Xiaolei Pei, et al.
Published: (2020-09-01) -
Defining Phenotype, Tropism, and Retinal Gene Therapy Using Adeno-Associated Viral Vectors (AAVs) in New-Born Brown Norway Rats with a Spontaneous Mutation in <i>Crb1</i>
by: Nanda Boon, et al.
Published: (2021-03-01) -
Evaluating Efficiencies of Dual AAV Approaches for Retinal Targeting
by: Livia S. Carvalho, et al.
Published: (2017-09-01) -
Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice
by: Kayla A. Quirin, et al.
Published: (2018-03-01) -
Efficient gene delivery and selective transduction of astrocytes in the mammalian brain using viral vectors
by: Nicolas eMerienne, et al.
Published: (2013-07-01)